October 20, 2016
CVS Health's Omnicare Inc. subsidiary will pay $2.24 million to settle allegations that it violated the False Claims Act by improperly billing government health care programs for prescription drugs prior to its acquisition by CVS last year, the U.S. Department of Justice announced Thursday.